She had been on the same osteoporosis medication for years. Every time her DEXA scan came back, the numbers were the same. Not better. Not worse. The same. Her doctor told her this was the medication working, that the drug was holding the decline steady, and that she should consider herself fortunate.
She was 68. Her vitamin D had been flagged as “too high” by her primary care physician, who told her to stop supplementing after her level came back at 33. She was also on omeprazole for acid reflux, a medication she had been taking for a decade.
Nobody had connected these dots. Nobody had told her that the combination of a bisphosphonate and a proton pump inhibitor comes with a documented 52% increased fracture risk compared to the bisphosphonate alone. Nobody had told her that 33 ng/mL of vitamin D is not even close to the 80 ng/mL that functional medicine targets for optimal bone mineral density. And nobody had ever considered starting her on bioidentical estrogen.
This is not a story about one patient. It is a story that plays out thousands of times a week in conventional medical offices across the country.
Why Women Bear the Brunt of Bone Loss
Osteoporosis disproportionately affects women, and the reason is hormonal. Specifically, it comes down to estradiol, the most potent of the three main estrogens.
Bone is not a static structure. It is metabolically active tissue that constantly remodels itself through two types of cells. Osteoclasts break down old or damaged bone. Osteoblasts build new bone. In a healthy hormonal environment, these two processes stay roughly in balance.
Estradiol acts as a brake on osteoclast activity. It slows the breakdown side of the equation. When a woman hits menopause and estradiol drops sharply, that brake comes off. Osteoclast activity accelerates. Bone breakdown begins to outpace bone building, particularly in the first 5 to 10 years after menopause. That is the window during which bone loss is most rapid and most consequential.
By the time a woman is diagnosed with osteoporosis, she has often been losing bone density at an accelerated rate for a decade or more.
The Screening Gap
Conventional medicine does not typically screen for osteoporosis until women are in their 50s or 60s. Insurance usually covers a DEXA scan starting at age 65. By that point, the most critical period of accelerated bone loss, the years immediately following menopause, has often already passed.
This is a structural failure of preventive care. The bone-building window in young women, ages 8 through the 20s, is when the body can create its strongest possible foundation for later life. The critical intervention window in perimenopausal and newly menopausal women is when hormonal support can prevent the most dramatic bone loss. Both windows close before conventional medicine typically pays attention.
A functional medicine approach advocates for earlier assessment, particularly in women with risk factors: family history of fractures, history of low body weight, long-term use of corticosteroids or proton pump inhibitors, early menopause, or a history of restrictive eating.
The Medications Making It Worse
Here is something most women on osteoporosis medication never hear: the other drugs in their medicine cabinet may be compounding the problem.
Proton pump inhibitors, the medications prescribed for acid reflux and heartburn, including omeprazole, pantoprazole, and their over-the-counter equivalents, impair calcium absorption. The acid-suppressing mechanism that helps with reflux also reduces the stomach’s ability to break down and absorb dietary calcium. A meta-analysis of nearly 60,000 people found that patients taking both a bisphosphonate and a PPI had a 52% increased fracture risk compared to those on the bisphosphonate alone. Not a modest increase. 52%.
SSRIs and SNRIs, the medications prescribed for depression and anxiety, carry their own documented bone risk. A 10-year Canadian study found that taking either type of antidepressant was associated with a 68% increased fracture risk. The mechanism involves elevated serotonin inhibiting osteoblast activity. The cells that build bone are suppressed, while the cells that break it down continue working at full capacity.
Synthetic corticosteroids, including prednisone, significantly increase osteoporosis risk with chronic use. Even chronically elevated cortisol from ongoing stress has a modest effect, stripping collagen from bone tissue and disrupting the cortisol-oxytocin balance that affects bone health.
None of these interactions are typically reviewed during a standard osteoporosis follow-up visit. The medication that is supposed to protect bones may be undermined by three other medications no one thought to connect.
What Vitamin D Actually Needs to Be
The vitamin D conversation reveals a fundamental gap between conventional and functional medicine targets.
Conventional medicine generally considers a vitamin D level of 30 ng/mL to be adequate. Functional medicine targets 60 to 80 ng/mL for optimal bone mineral density, and research supports this distinction. Calcium absorption is not optimized until vitamin D is in that higher range. Toxicity is generally not seen until levels around 150 ng/mL, leaving a large safe window between conventional “adequate” and where bone health actually benefits.
Calcium itself requires context. The body cannot absorb more than approximately 500 milligrams at one time. High single doses offer no additional benefit. Calcium citrate is more absorbable than the more common calcium carbonate form. And critically, vitamin K2 must be present to direct absorbed calcium to bones rather than arterial walls. Calcium supplementation without adequate K2 can increase cardiovascular risk rather than reducing it.
These nuances are not communicated in a typical five-minute bone density conversation.
Bioidentical Estradiol: The Most Effective Single Intervention
Among all the tools available for preventing and partially reversing post-menopausal bone loss, bioidentical estradiol is the most effective single intervention.
The optimal window is before or within the first 5 to 10 years after menopause. This is when the osteoclast acceleration is at its highest and when hormonal intervention has the most potential to stop the damage. After age 60, gains are harder to achieve, but the benefits still outweigh the risks for most women. As one functional medicine provider noted: it is better than no intervention, and it is still safe.
The key distinction between bioidentical estradiol and the synthetic conjugated equine estrogen used in the Women’s Health Initiative study of 2002, the study that triggered decades of fear around HRT, is molecular. Bioidentical hormones are molecularly identical to the body’s own hormones. Synthetic hormones are similar but not identical. The 2002 study used conjugated equine estrogen, not bioidentical estradiol, and the medical community’s blanket response of pulling all HRT was not proportionate to what the data actually showed.
Transdermal estradiol, applied as a cream or patch, bypasses the liver and does not carry the blood clot risks associated with oral estrogen. It is the preferred delivery route for bone protection and overall safety.
Exercise, Protein, and Fall Prevention
Hormones and nutrients do not work in isolation. The mechanical component of bone health is equally important.
Bones need resistance to stay dense. Cardiovascular exercise, swimming, cycling, walking on a flat surface, does not provide the load-bearing stress that stimulates bone formation. Weight-bearing and resistance exercise does. The astronaut analogy is apt: without gravity pressing against their bones, astronauts lose bone density rapidly in space, regardless of how physically fit they are. The body requires mechanical stress to maintain bone density.
Protein intake also matters more than most bone health discussions acknowledge. A rough calculation: multiply body weight in pounds by 0.59 to get a daily gram target as a starting point. A 140-pound woman needs approximately 65 grams of protein per day at minimum, more if she is actively trying to build or preserve muscle mass.
And because even optimal bone density cannot guarantee safety from falls, fall prevention is a legitimate medical priority. Removing throw rugs, installing grab bars near toilets and in showers, improving hallway lighting, eliminating raised thresholds between rooms: these changes reduce fracture risk as concretely as any supplement or medication.
The Hopelessness Is Not Warranted
Women with osteoporosis often arrive at functional medicine consultations feeling like they have run out of options. Years of medication. No improvement on their DEXA scan. No clear explanation for why.
There are more tools available than the standard pharmaceutical approach. Addressing vitamin D to functional levels. Eliminating medications that compound fracture risk when safer alternatives exist. Starting bioidentical estradiol, even later in life. Shifting from pure cardio to weight-bearing exercise. Correcting gut health issues that are limiting calcium absorption.
These are not experimental approaches. They are evidence-based interventions that conventional medicine either does not have time to discuss or has not been trained to connect.
The prevention window for bone health is wide open in younger women. For older women already dealing with bone loss, the window for improvement is narrower but far from closed.
About the Author: Dr. Sasha Rose is a naturopathic physician and licensed acupuncturist at Med Matrix, a functional medicine clinic in South Portland, Maine. She specializes in women’s hormone health, bioidentical hormone therapy, and root-cause approaches to perimenopause and menopause.